Indicators of the Hemostasis System in the Blood of Patients with Covid-19 Complicated Hypertension of Both Stages

Abstract

Currently, the number of complications associated with COVID-19 is continuously increasing worldwide. The issue of predicting the clinical course of the disease in patients on the basis of pathological changes in early and late complications of the disease, including concomitant high-risk diseases, and the selection of drug therapy in accordance with the severity of the course of the disease remains difficult and debatable (Hajizadeh F., 2021; Lloyd-Jones G., 2021). The question of the development of COVID-19, associated with the reaction of the local immune system to SARS-CoV-2, and the role of the oral mucosa in the formation of a pathological condition remains debatable (Huang N., 2021).